Risk factors of dermatophytosis among Korean adults

[1]  R. Hay,et al.  A systematic review of worldwide data on tinea capitis: analysis of the last 20 years , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  Y. Sasagawa.  Internal environment of footwear is a risk factor for tinea pedis , 2019, The Journal of dermatology.

[3]  Sanjay Singh,et al.  Risk factors for chronic and chronic-relapsing tinea corporis, tinea cruris and tinea faciei: Results of a case-control study. , 2019, Indian journal of dermatology, venereology and leprology.

[4]  Murali Subramaniyam,et al.  Development of an Algorithm for Stroke Prediction: A National Health Insurance Database Study in Korea , 2018, European Neurology.

[5]  N. Shear,et al.  Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment , 2017, Journal of cutaneous medicine and surgery.

[6]  S. Rudman,et al.  Epidemiology and Clinical Features , 2017 .

[7]  Weida Liu,et al.  The Changing Face of Dermatophytic Infections Worldwide , 2017, Mycopathologia.

[8]  S. Oninla,et al.  Superficial Mycoses in Relation to Age and Gender , 2016 .

[9]  B. Elewski,et al.  Risk Factors and Comorbidities for Onychomycosis: Implications for Treatment with Topical Therapy. , 2015, The Journal of clinical and aesthetic dermatology.

[10]  M. Ilkit,et al.  Tinea pedis: The etiology and global epidemiology of a common fungal infection , 2015, Critical reviews in microbiology.

[11]  Euichul Shin,et al.  Effect of health insurance type on health care utilization in patients with hypertension: a national health insurance database study in Korea , 2014, BMC Health Services Research.

[12]  Hwa Young Choi,et al.  Prevalence of fungal infections using National Health Insurance data from 2009-2013, South Korea , 2014, Epidemiology and health.

[13]  B. Elewski,et al.  The epidemiology, etiology, and pathophysiology of onychomycosis. , 2013, Seminars in cutaneous medicine and surgery.

[14]  G. Millington,et al.  Obesity and the skin , 2011, The British journal of dermatology.

[15]  M. Friedrich,et al.  Epidemiological trends in skin mycoses worldwide , 2008, Mycoses.

[16]  H. Degreef.  Clinical Forms of Dermatophytosis (Ringworm Infection) , 2008, Mycopathologia.

[17]  J. Bouchara,et al.  Updates on the Epidemiology of Dermatophyte Infections , 2008, Mycopathologia.

[18]  M. Hsieh,et al.  Metabolic syndrome associated with toenail onychomycosis in Taiwanese with diabetes mellitus , 2008, International journal of dermatology.

[19]  C. K. Campbell,et al.  Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades. , 2007, Medical mycology.

[20]  M. Falagas,et al.  Obesity and infection. , 2006, The Lancet. Infectious diseases.

[21]  R. Hay,et al.  Patients at risk of onychomycosis – risk factor identification and active prevention , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[22]  R. Schwartz,et al.  Intertrigo and common secondary skin infections. , 2005, American family physician.

[23]  G. Fantuzzi.  Adipose tissue, adipokines, and inflammation. , 2005, The Journal of allergy and clinical immunology.

[24]  M. Ellabib,et al.  Dermatophytes and other fungi associated with skin mycoses in Tripoli, Libya. , 2001, Mycoses.

[25]  M. Ellabib,et al.  Dermatophytes and other fungi associated with skin mycoses in Tripoli, Libya , 2002, Annals of Saudi medicine.

[26]  S. Coppack.  Pro-inflammatory cytokines and adipose tissue , 2001, Proceedings of the Nutrition Society.

[27]  E. Haneke,et al.  The scope of onychomycosis: epidemiology and clinical features , 1999, International journal of dermatology.

[28]  B. Elewski,et al.  Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. , 1997, Archives of dermatology.

[29]  Karen Steindorf,et al.  Results of a case-control study on previous infections and other risk factors for ischemic cerebrovascular diseases: attributable and absolute risks , 1996, GMDS.